Galmed Pharmaceuticals Ltd (GLMD) Live Share Price, Invest From India

Galmed Pharmaceuticals Ltd Stock Performance

as on April 3, 2026 at 6:59 am IST

Day's Low
Day's High
$0.49
Day's Price Range
$0.55
$0.54
9.26%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
$0.41
52-Week Price Range
$2.68
$0.54
23.87%
Downside
396.30%
Upside

Galmed Pharmaceuticals Ltd share price movements today

Previous Close: $0.53
Open: $0.53
Volume: 191.8K
Day's Low - High: $0.49 - $0.55
52 Week Low - High: $0.41 - $2.68

Galmed Pharmaceuticals Ltd Historical Returns

1 Month Return: -8.1 %
3 Month Return: -34.38 %
1 Year Return: -59.7 %
3 Year Return: -99.18 %
5 Year Return: -99.91 %

Galmed Pharmaceuticals Ltd Stock Fundamentals & Key Indicators

Check Galmed Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6M

EPS (TTM)

-0.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-46.34%

Galmed Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Galmed Pharmaceuticals Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Galmed Pharmaceuticals Ltd	BUY	$3.6M	-99.91%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	124.84%	136.85	8.45%
Beone Medicines Ltd	NA	$35.7B	NA	125.83	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	105.93%	28.66	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	60.41%	18.38	31.41%

Stock Returns calculator for Galmed Pharmaceuticals Ltd Stock including INR - Dollar returns

The Galmed Pharmaceuticals Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Galmed Pharmaceuticals Ltd investment value today

Current value as on today

₹43,663

Returns

-₹56,337

(-56.34%)

Returns from Galmed Pharmaceuticals Ltd Stock

-₹59,701 (-59.7%)

Dollar Impact

₹3,364 (+3.36%)

Analyst Recommendation on Galmed Pharmaceuticals Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Galmed Pharmaceuticals Ltd. Average target price of $12

Galmed Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on Galmed Pharmaceuticals Ltd.

What analysts predicted

95.5%UPSIDE

Target Price

$12

Current Price

$0.54

Analyzed by

7 Analysts

Target

$12.00

Galmed Pharmaceuticals Ltd target price $12, a slight upside of 95.5% compared to current price of $0.54. According to 7 analysts rating.

Galmed Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Galmed Pharmaceuticals Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 5, 2026 to April 4, 2026

Change:-23% versus previous 30 day period

Galmed Pharmaceuticals Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-	0	0	-	-	-	-	-
Operating Income	-1	-1	-2	-1	-1	-2	-1	-1	-2	-2
EBITDA	-1	-1	-	-1	-1	-2	-	-1	-2	-2
Interest Expense	-	0	-	-	-	-	-	0	-	-
Depreciation	0	0	0	0	0	-	-	-	-	-
Income Before Tax	-1	-1	-2	-1	-1	-1	-3	-1	-2	-1
Income Tax Expense	0	0	-	0	-	-	-	-	-	-
Net Income	-1	-1	-2	-1	-1	-1	-3	-1	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galmed Pharmaceuticals Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	1	2	-	-	-	-	-	-
Gross Profit	0	0	1	2	0	0	0	0	0	0
Operating Income	-10	-16	-12	-10	-22	-30	-32	-17	7	-6
EBITDA	-10	-16	-12	-10	-22	-30	-32	-17	-6	-7
Interest Expense	-	0	0	0	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-10	-16	-12	-9	-20	-28	-32	-17	-6	-7
Income Tax Expense	21	0	12	0	-1	-1	0	0	-14	-
Net Income	-10	-16	-12	-9	-18	-27	-31	-18	-6	-7
Net Profit Margin	0.00%	-3630.19%	-1133.55%	-483.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galmed Pharmaceuticals Ltd Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-1	-2	-1	-1	-1	-3	-1	-2	-1
Operating Cash Flow	-2	0	-1	-1	-1	-1	-1	-1	-1
Investing Cash Flow	-3	-	0	1	0	-	0	-4	0
Financing Cash Flow	6	-	-	-	8	0	1	6	0
Change in Cash	0	1	-1	0	7	-5	0	0	-1

Galmed Pharmaceuticals Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-12	-9	-20	-28	-32	-17	-6	-7
Operating Cash Flow	-12	-12	-9	-14	-26	-32	-18	-6	-5
Investing Cash Flow	6	6	-60	6	16	11	17	0	-1
Financing Cash Flow	4	15	80	0	0	17	0	6	8
Change in Cash	-1	9	11	-8	-8	-4	0	0	1

Global Institutional Holdings in Galmed Pharmaceuticals Ltd

Funds	Holdings
Two Sigma Investments LLC	1.7%
TSFG, LLC	0%
Wells Fargo & Co	0%
Sontag Advisory LLC	0%
ZRC WEALTH MANAGEMENT, LLC	0%

See all

Insights on Galmed Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 57.3% return, outperforming this stock by 156.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 95.0%
NEGATIVE IMPACT
Price Dip
In the last 6 months, GLMD stock has moved down by -65.6%

About Galmed Pharmaceuticals Ltd

galmed pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of aramchol, a novel, once-daily, oral therapy for treating liver diseases utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or fabacs. aramchol is initially being developed for treating non-alcoholic steato-hepatitis, or nash, a chronic disease affecting a large population, for treating patients who also suffer from obesity and insulin resistance. galmed pharmaceuticals galmed’s business has been, in its current legal structure, was incorporated in israel on july 31, 2013 as a privately held company. however, operating since 2000 under a different group of companies established in the same year. galmed was co-founded by professor tuvia gilat and allen baharaff, based on professor gilat’s extensive research in fabac’s and nash.

Organisation	Galmed Pharmaceuticals Ltd
Headquarters	16 Abba Hillel Road, Ramat Gan, Israel, 5250608
Industry	Health Technology
CEO	Mr. Allen Baharaff
E-voting on shares	Click here to vote

Key Management of Galmed Pharmaceuticals Ltd

Name	Title
Mr. Yohai Stenzler CPA	Chief Accounting Officer
Dr. Liat Hayardeny MBA, Ph.D.	Chief Scientific Officer
Dr. Tali Gorfine	Medical Consultant
Mr. Allen Baharaff	Co-Founder, President, CEO & Chairman
Mr. Doron Cohen	Chief Financial Officer
Mr. Guy Nehemya	COO & Data Protection Officer

FAQs

What is Galmed Pharmaceuticals Ltd share price today?

Galmed Pharmaceuticals Ltd share price today is $0.54 as on April 3, 2026 at 1:29 am IST at the close of the market. Galmed Pharmaceuticals Ltd share today touched a day high of $0.55 and a low of $0.49.

What is the 52 week high and 52 week low for Galmed Pharmaceuticals Ltd share?

Galmed Pharmaceuticals Ltd share touched a 52 week high of $2.68 on April 28, 2025 and a 52 week low of $0.41 on March 27, 2026. Galmed Pharmaceuticals Ltd stock price today i.e. April 3, 2026 at 1:29 am IST is closed at $0.54,which is 79.85% down from its 52 week high and 31.35% up from its 52 week low.

What is Galmed Pharmaceuticals Ltd's market capitalisation today?

Galmed Pharmaceuticals Ltd market capitalisation is $0.00T as on April 3, 2026 at 1:29 am IST.

How to invest in Galmed Pharmaceuticals Ltd Stock (GLMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Galmed Pharmaceuticals Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galmed Pharmaceuticals Ltd Shares that will get you 2.7778 shares as per Galmed Pharmaceuticals Ltd share price of $0.54 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Galmed Pharmaceuticals Ltd Stock (GLMD) from India?

Indian investors can start investing in Galmed Pharmaceuticals Ltd (GLMD) shares with as little as ₹92.67 or $1 (as of April 4, 2026 at 8:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Galmed Pharmaceuticals Ltd stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 8:41 pm IST). Based on Galmed Pharmaceuticals Ltd share’s latest price of $0.54 as on April 3, 2026 at 1:29 am IST, you will get 18.5185 shares of Galmed Pharmaceuticals Ltd. Learn more about fractional shares .

What are the returns that Galmed Pharmaceuticals Ltd has given to Indian investors in the last 5 years?

Galmed Pharmaceuticals Ltd stock has given -99.91% share price returns and 27.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?